|
|
||||||||
|
FIGURE 5. Monitoring chemoradiation. (A) Pretreatment transaxial 18F-FDG PET/CT revealed intensely hypermetabolic primary carcinoma at base of tongue (red arrows). (B) 18F-FDG PET/CT after chemoradiation revealed complete resolution of abnormal activity without evidence of residual disease in treated region.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |